Acorda therapeutics says intends to provide additional inbrija launch updates on q3 2019 conference call

Acorda therapeutics inc - providing an update on managed care access for inbrija™ (levodopa inhalation powder).acorda therapeutics inc - intends to provide additional inbrija launch updates on its q3 2019 conference call scheduled for nov 4, 2019.acorda therapeutics-inbrija is now available in u.s. without need for medical exception for about 66% of commercial, about 25% of medicare plan lives.
ACOR Ratings Summary
ACOR Quant Ranking